Skip to main navigation
ZyVersa Therapeutics, Inc. logo
  • Overview
  • News & Events
    • News Releases
    • Events
    • Annual Meeting
    • ZyVersa in the News
    • Media Resources
  • Financials & Filings
    • Overview
    • All SEC Filings
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board of Directors
    • Committee Composition
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Investor Resources
    • Investor FAQs
    • Presentations
    • Email Alerts
    • Contact IR

SEC Filing

SEC Filing Details

Document Details

Form
8-K
Filing Date
Mar 5, 2026
Document Date
Feb 27, 2026
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
ZyVersa Therapeutics, Inc.
Issuer
ZYVERSA THERAPEUTICS, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL LABEL FILE
EX-101.PRE - XBRL PRESENTATION FILE
XML - XBRL INSTANCE DOCUMENT
Print Page
Email Alerts
Contact IR
ZyVersa Therapeutics, Inc. logo
  • About
  • Inflammasomes
  • Renal Lipids
  • Pipeline
  • Careers
  • Investors & Media
  • Contact
  • ©2026 ZyVersa Therapeutics, Inc. All rights reserved.
  • Privacy Policy
  • Disclaimer
  • Trademarks
  • Sitemap